Chung Christine's Form 4/A amendment
AmendedKyntra Bio, Inc.KYNB · filed Jan 4, 2023
- Accession no.
- 0001209191-23-001354
- Filed
- Jan 4, 2023
- Trade date
- Dec 8, 2022
- Filing delay
- 27 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Dec 9, 2022
This filing lists 1 non-derivative transaction. Open-market sales total $41.0K. It was filed 27 days after the trade.
This amendment replaces 0001209191-22-060582 (filed Dec 9, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chung ChristineCIK 0001775295 | Officer (SVP, China Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Common Stock | SSaleDisposed | −2,595 | $15.79 | −$40,975.05 | 234,873 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Remarks
This Form 4/A is being filed to correct the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units.